Cargando…

Relationship between the neutrophil to high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with stable coronary artery disease

OBJECTIVE: To evaluate the link between the neutrophil to HDL-C ratio (NHR) and the degree of coronary stenosis in patients with stable coronary artery disease (CAD). MATERIALS AND METHODS: Totally 766 individuals who attended our clinic for coronary angiography between January 2019 and January 2021...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Jie, Lu, Jun, Sha, Wenjun, Xu, Bilin, Zhang, Cuiping, Wang, Hongping, Xia, Juan, Zhang, Hong, Tang, Wenjun, Lei, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729241/ https://www.ncbi.nlm.nih.gov/pubmed/36505389 http://dx.doi.org/10.3389/fcvm.2022.1015398

Ejemplares similares

Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development
por: Wu, Dongmei, et al.
Publicado: (2021)

Predictive Value of Non-high-Density Lipoprotein Cholesterol and Neutrophil-Lymphocyte Ratio for Coronary Artery Vulnerable Plaques in Type 2 Diabetes Mellitus
por: Huang, Xiyi, et al.
Publicado: (2022)

Utility of neutrophil-to-high-density lipoprotein-cholesterol ratio in patients with coronary artery disease: a narrative review
por: Lamichhane, Pratik, et al.
Publicado: (2023)

Association between the Non-high-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio and the Risk of Coronary Artery Disease
por: You, Jiayin, et al.
Publicado: (2020)

The Association of Syntax Score with Levels of Lipoprotein(a) and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease and Different Low-Density Lipoprotein Cholesterol Levels
por: Xu, Weifeng, et al.
Publicado: (2020)

Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins
por: Wang, Le, et al.
Publicado: (2021)

Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients
por: Yao, Younan, et al.
Publicado: (2022)

Nomograms Based on the Albumin/Neutrophil-to-Lymphocyte Ratio Score for Predicting Coronary Artery Disease or Subclinical Coronary Artery Disease
por: Wei, Chen, et al.
Publicado: (2023)

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
por: Zhang, Shuang, et al.
Publicado: (2022)

Association of High Density Lipoprotein with Platelet to Lymphocyte and Neutrophil to Lymphocyte Ratios in Coronary Artery Disease Patients
por: Prajapati, Jayesh H., et al.
Publicado: (2014)

Coronary Revascularization in Patients With Stable Coronary Artery Disease: The Role of Imaging
por: Neglia, Danilo, et al.
Publicado: (2021)

Achieved low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio predicts the pathophysiological evolution of lipid-rich plaques in acute coronary syndromes: an optical coherence tomography study
por: He, Luping, et al.
Publicado: (2023)

Oxidized Low-Density Lipoprotein Cholesterol and the Ratio in the Diagnosis and Evaluation of Therapeutic Effect In Patients with Coronary Artery Disease
por: Huang, Huiling, et al.
Publicado: (2012)

Monocyte-to-High Density Lipoprotein Cholesterol Ratio Positively Predicts Coronary Artery Disease and Multi-Vessel Lesions in Acute Coronary Syndrome
por: Du, Guo-Li, et al.
Publicado: (2023)

Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
por: Elsadek Seaoud, Elshaimaa Aly M., et al.
Publicado: (2022)

Impact of low-density lipoprotein cholesterol and lipoprotein(a) on mid-term clinical outcomes following coronary artery bypass grafting: A secondary analysis of the DACAB trial
por: Yu, Qixiang, et al.
Publicado: (2023)

CYP2C19 metabolizer phenotypes may affect the efficacy of statins on lowering small dense low-density lipoprotein cholesterol of patients with coronary artery disease
por: Dai, Ruozhu, et al.
Publicado: (2022)

Low-Density Lipoprotein Cholesterol Levels in Coronary Artery Disease Patients: Opportunities for Improvement
por: Martin, Gary J., et al.
Publicado: (2022)

Extremely high high‐density lipoprotein cholesterol with coronary artery disease: Case report
por: Sawalha, Khalid, et al.
Publicado: (2021)

Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Wu, Ting-Ting, et al.
Publicado: (2019)

Influence of high-density lipoprotein cholesterol on coronary collateral formation in a population with significant coronary artery disease
por: Hsu, Po-Chao, et al.
Publicado: (2013)

Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease
por: Krychtiuk, Konstantin A., et al.
Publicado: (2014)

Low High-Density Lipoprotein Cholesterol Predisposes to Coronary Artery Ectasia
por: Jafari, Jamal, et al.
Publicado: (2019)

Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease
por: Helgadottir, Anna, et al.
Publicado: (2018)

Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol Depends on Polygenic Background
por: Bolli, Alessandro, et al.
Publicado: (2021)

Neutrophil Activation Status in Stable Coronary Artery Disease
por: Särndahl, Eva, et al.
Publicado: (2007)

Monocyte to high-density lipoprotein ratio is associated with mortality in patients with coronary artery diseases
por: Pei, Gaiqin, et al.
Publicado: (2023)

Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Different Metabolic Phenotypes
por: Jin, Jing-Lu, et al.
Publicado: (2022)

An elevated monocyte-to-high-density lipoprotein–cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI
por: Zhang, Da-Peng, et al.
Publicado: (2020)

Prognostic Role of Neutrophil to High-Density Lipoprotein Cholesterol Ratio for All-Cause and Cardiovascular Mortality in the General Population
por: Jiang, Ming, et al.
Publicado: (2022)

Comparison of the Predicting Value of Neutrophil to high-Density Lipoprotein Cholesterol Ratio and Monocyte to high-Density Lipoprotein Cholesterol Ratio for in-Hospital Prognosis and Severe Coronary Artery Stenosis in Patients with ST-Segment Elevation Acute Myocardial Infarction Following Percutaneous Coronary Intervention: A Retrospective Study
por: Guo, Jiongchao, et al.
Publicado: (2023)

Predictors of poor coronary collateral development in patients with stable coronary artery disease: Neutrophil-to-lymphocyte ratio and platelets
por: Akın, Fatih, et al.
Publicado: (2015)

Predictors of poor coronary collateral development in patients with stable coronary artery disease: Neutrophil-to-lymphocyte ratio and platelets
por: Gülşen, Kamil, et al.
Publicado: (2016)

The relationship between triglyceride/high-density lipoprotein cholesterol ratio and coronary microvascular disease
por: Liao, Li ping, et al.
Publicado: (2023)

Comparative Platelet Releasate Proteomic Profiling of Acute Coronary Syndrome versus Stable Coronary Artery Disease
por: Maguire, Patricia B., et al.
Publicado: (2020)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease
por: Shui, Xing, et al.
Publicado: (2023)

Dyslipidemia and Rate of Under-Target Low-Density Lipoprotein-Cholesterol in Patients with Coronary Artery Disease in Korea
por: Lee, Sang-Hak, et al.
Publicado: (2019)

Personalized Medicine beyond Low-Density Lipoprotein Cholesterol to Combat Residual Risk for Coronary Artery Disease
por: Tada, Hayato
Publicado: (2021)

High-Density Lipoprotein Cholesterol Efflux Capacity as a Novel Prognostic Surrogate for Coronary Artery Disease
por: Hisauchi, Itaru, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_csrhjivm8ev5q24sfuq77tl4jr